Table 3.
Sensitivity analyses of mortality risk in SARS-CoV-2-positive cases
| Excluding hospitalised patients | Excluding patients requiring IMV | Excluding patients admitted to ICU | |
|---|---|---|---|
| Obesity model | |||
| Without comorbidities | Reference | ||
| Obesity alone | 3.13 (1.71–5.75) | 2.37 (1.89–2.97) | 2.50 (2.02–3.09) |
| DM model | |||
| Without comorbidities | Reference | ||
| DM alone | 2.90 (1.53–5.50) | 2.17 (1.73–2.74) | 2.06 (1.64–2.59) |
| Obesity alone | 2.98 (1.63–5.45) | 2.32 (1.85–2.90) | 2.46 (1.99–3.05) |
| DM + obesity | 2.04 (0.62–6.73) | 2.66 (1.83–3.85) | 2.90 (2.05–4.11) |
| COPD model | |||
| Without comorbidities | Reference | ||
| COPD alone | 2.39 (0.51–11.17) | 1.66 (0.92–2.99) | 1.61 (0.89–2.89) |
| Obesity alone | 3.13 (1.71–5.74) | 2.37 (1.89–2.97) | 2.52 (2.03–3.12) |
| COPD + obesity | 7.05 (0.93–53.21) | 2.25 (0.71–7.08) | 1.19 (0.69–6.88) |
| Asthma model | |||
| Without comorbidities | Reference | ||
| Asthma alone | Not estimable | 0.42 (0.10–1.68) | 0.20 (0.03–1.40) |
| Obesity alone | 3.13 (1.71–5.75) | 2.37 (1.89–2.97) | 2.50 (2.02–3.10) |
| Asthma + obesity | Not estimable | 1.71 (0.55–2.97) | 1.63 (0.52–5.11) |
| Immunosuppression model | |||
| Without comorbidities | Reference | ||
| Immunosupp. alone | 2.68 (0.36–19.71) | 2.65 (1.45–4.87) | 2.83 (1.58–5.07) |
| Obesity alone | 3.11 (1.69–5.70) | 2.35 (1.88–2.95) | 2.49 (2.01–3.08) |
| Immunosuppression + obesity | Not estimable | 6.38 (2.84–14.35) | 5.63 (2.32–13.66) |
| Hypertension model | |||
| Without comorbidities | Reference | ||
| Hypertension alone | 1.32 (0.67–2.58) | 1.31 (0.03–1.67) | 1.39 (1.10–1.76) |
| Obesity alone | 3.17 (1.74–5.80) | 2.37 (1.89–2.96) | 2.50 (2.02–3.09) |
| Hypertension + obesity | 2.51 (1.05–6.01) | 1.99 (1.43–2.77) | 2.14 (1.59–2.93) |
| CVD model | |||
| Without comorbidities | Reference | ||
| CVD alone | Not estimable | 1.64 (0.81–3.32) | 1.57 (0.78–3.17) |
| Obesity alone | 3.13 (1.71–5.75) | 2.38 (1.89–2.97) | 2.51 (2.03–3.10) |
| CVD + obesity | Not estimable | Not estimable | 0.81 (0.11–5.77) |
| CKD model | |||
| Without comorbidities | Reference | ||
| CKD alone | Not estimable | 0.92 (0.23–3.3.69) | 0.38 (0.05–2.72) |
| Obesity alone | 3.13 (1.71–5.75) | 2.37 (1.89–2.97) | 2.50 (0.02–3.09) |
| CKD + obesity | Not estimable | Not estimable | 5.65 (0.79–40.52) |
95% CI, 95% confidence interval; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; DM, diabetes mellitus; HR, hazard ratio; ICU, intensive care unit; IMV, invasive mechanical ventilation.
Data presented as HR (95% CI).
All models were adjusted by sex, age, SLI, ageing index, afro-descendant per 100 inhabitants, indigenous language-speaking per 100 inhabitants, affiliation to health services per 100 inhabitants, members per household, hospitals per 10 000 inhabitants, hospital beds per 10 000 inhabitants.